Pestian Lab
Childhood Absence Epilepsy (CAE)

Childhood Absence Epilepsy (CAE) Study

The Childhood Absence Epilepsy (CAE) study is a randomized, double blind, comparative trial of ethosuximide (ETX), lamotrigine (LTG) and valproic acid (VPA) as initial monotherapy for children with CAE. The primary objective is to identify the optimal anticonvulsant (i.e. the AED with highest rate of seizure control and lowest incidence of treatment limiting toxicity) used for initial treatment based on short-term and long-term outcomes.

> Return to the Epilepsy Research page

Give Today

3333 Burnet Avenue, Cincinnati, Ohio 45229-3026

© 1999-2024 Cincinnati Children's Hospital Medical Center. All rights reserved.

U.S. News & World Report Honor Roll Badge for Top Children's Hospital.Best Places to Work.America's Best Large Employers